Zymeworks upgraded by Leerink Partners with a new price target

11/7/24 6:47:25 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Leerink Partners upgraded Zymeworks from Market Perform to Outperform and set a new price target of $25.00 from $10.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$ZYME

Date	Price Target	Rating	Analyst
5/20/2025		Buy	TD Cowen
12/16/2024	$18.00	Neutral → Overweight	Analyst
11/7/2024	$10.00 → $25.00	Market Perform → Outperform	Leerink Partners
11/1/2024	$12.00	Overweight → Equal Weight	Wells Fargo
3/21/2023	$12.00	Overweight	Wells Fargo
1/4/2023	$10.00 → $8.00	Neutral	H.C. Wainwright
12/20/2022	$7.70 → $11.00	Hold → Buy	Jefferies
11/1/2022	$40.00 → $8.00	Buy → Neutral	H.C. Wainwright